Edwards Lifesciences Corporation (EW) Stock

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is led by CEO Bernard J. Zovighian, employs 15,800 people, headquartered in Irvine, US, publicly traded since 2000.

Edwards Lifesciences Corporation (EW) stock trades at $85.21 with a market capitalization of $49.06B. The stock is valued at a price-to-earnings (P/E) ratio of 49.59, price-to-book of 4.68, price-to-sales of 7.63. Over the past 52 weeks the stock has ranged between $72.30 and $96.29, and currently trades 11.5% below its 52-week high.

On profitability, Edwards Lifesciences Corporation generates a return on equity (ROE) of 9.69%, return on capital employed of 14.80%, an operating margin of 26.96%, a net profit margin of 15.43%.

In its most recent fiscal year, Edwards Lifesciences Corporation reported annual revenue of $6.1B, net profit of $1.1B, revenue has compounded at 6.7% a year over the last five years, profit at 5.5% a year.

The balance sheet shows a debt-to-equity ratio of 0.07 — a conservative balance sheet with little leverage risk, a current ratio of 3.71, total assets of $13.7B, $2.9B in cash and equivalents.

EW has a beta of 0.85.